Outlook Therapeutics Management
Management criteria checks 2/4
Outlook Therapeutics' CEO is Russ Trenary, appointed in Jul 2021, has a tenure of 2.75 years. total yearly compensation is $1.76M, comprised of 34.1% salary and 65.9% bonuses, including company stock and options. directly owns 0.7% of the company’s shares, worth €1.20M. The average tenure of the management team and the board of directors is 2.5 years and 4.8 years respectively.
Key information
Russ Trenary
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 34.1% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.5yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$51m |
| Sep 30 2023 | US$2m | US$600k | -US$59m |
| Jun 30 2023 | n/a | n/a | -US$60m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | n/a | n/a | -US$70m |
| Sep 30 2022 | US$1m | US$600k | -US$66m |
| Jun 30 2022 | n/a | n/a | -US$65m |
| Mar 31 2022 | n/a | n/a | -US$60m |
| Dec 31 2021 | n/a | n/a | -US$53m |
| Sep 30 2021 | US$8m | US$145k | -US$53m |
Compensation vs Market: Russ's total compensation ($USD1.76M) is above average for companies of similar size in the German market ($USD702.03K).
Compensation vs Earnings: Russ's compensation has increased whilst the company is unprofitable.
CEO
Russ Trenary (65 yo)
2.8yrs
Tenure
US$1,758,862
Compensation
Mr. C. Russell Trenary, III, also known as Russ, serves as a President, Chief Executive Officer and Director at Outlook Therapeutics, Inc., since July 06, 2021. He served as the Chief Executive Officer and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Executive Chairman | 6yrs | US$242.50k | 0.0027% € 4.5k | |
| President | 2.8yrs | US$1.76m | 0.70% € 1.2m | |
| Executive VP | 8.6yrs | no data | 0.0042% € 7.3k | |
| Chief Commercial Officer | 5.4yrs | US$718.20k | 0.18% € 310.1k | |
| Senior Vice President | 2.1yrs | no data | no data | |
| Senior Vice President of Licensing and M&A | 2.2yrs | no data | no data | |
| Senior Vice President of Medical Affairs | 1.3yrs | no data | no data | |
| Senior Vice President of Clinical Development & Regulatory Affairs | no data | no data | no data | |
| Senior VP - Head of Europe | less than a year | no data | no data |
2.5yrs
Average Tenure
61yo
Average Age
Experienced Management: 41ON's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Executive Chairman | 6yrs | US$242.50k | 0.0027% € 4.5k | |
| President | 2.8yrs | US$1.76m | 0.70% € 1.2m | |
| Executive VP | 5.7yrs | no data | 0.0042% € 7.3k | |
| Independent Director | 8.3yrs | US$95.00k | 0.11% € 181.5k | |
| Independent Director | 1.7yrs | US$79.00k | 0% € 0 | |
| Independent Non-Employee Director | 4yrs | US$112.50k | 0% € 0 | |
| Board Observer | no data | no data | no data | |
| Independent Non-Employee Director | 4yrs | US$79.00k | 0% € 0 | |
| Independent Director | 6.6yrs | US$113.00k | 0.015% € 26.1k | |
| Independent Director | 6.5yrs | US$110.00k | 0.023% € 38.7k | |
| Independent Director | 3.8yrs | US$75.00k | 0% € 0 |
4.8yrs
Average Tenure
62yo
Average Age
Experienced Board: 41ON's board of directors are considered experienced (4.8 years average tenure).